Not all tech stocks are guaranteed winners.
Just after the 2020 presidential election, tech stocks continued to climb.
The announcement of favorable tests of new coronavirus vaccines has had an unintended consequence on other market avenues.
And then favorable COVID-19 vaccine news this week pushed investors into other sectors, triggering a tech stock sell-off.
Investors Dump Some Tech Stocks
The tech-heavy Nasdaq Composite Index fell 1.4% on Monday. Comparatively, the small-cap Russell 2000 jumped up 1.9%.
The iShares Global Tech ETF (NYSE: IXN) — an exchange-traded fund (ETF) tracking notable tech stocks — jumped more than 77% since reaching a low in March 2020.
But after hitting that high, the ETF pared-back 11%. It inched a bit higher but started trending down at the beginning of this week.
The ETF holds technology companies like Apple Inc. (Nasdaq: AAPL), Microsoft Corp. (Nasdaq: MSFT) and NVIDIA Corp. (Nasdaq: NVDA).
Tech ETF Bounces Back and Forth
In this episode of The Bull & The Bear, I’ll talk with contributor Charles Sizemore about two tech stocks and whether they are diamonds for your portfolio or ones to pass on.
We’ll examine what these companies do and how they’ve performed recently.
What’s even better is you’ll get insight on what you should do with these two tech stocks — if you are thinking about buying or already have them in your portfolio.
Remember, knowing the data and the details about a specific company helps you determine whether it is worth investing in.
That’s why we do the work for you and give you our analysis of each one.
The Bull & The Bear
Led by Adam and a team of finance journalists, traders and experts, Money & Markets gives you the information you need to protect your nest egg, grow your wealth and safeguard your financial well-being.
Be sure to also subscribe to our YouTube channel for more videos and information.
Have something you want us to talk about? Are you investing in tech stocks? Email us at firstname.lastname@example.org and give us your thoughts.
Check out moneyandmarkets.com and sign up for our free newsletters that deliver you the most important and unbiased financial news, commentary and actionable advice.
Also, follow us on:
Research Analyst, Money & Markets
Matt Clark is the research analyst for Money & Markets. He’s the host of our podcast, The Bull & The Bear, as well as the Marijuana Market Update. Before joining the team, he spent 25 years as an investigative journalist and editor — covering everything from politics to business.